More than 80 leading international pharmaceutical, generics, diagnostics and biotechnology companies, as well as key industry bodies, have come together to call on governments and industry to work in parallel in taking comprehensive action against drug resistant infections so called ‘superbugs’ – with a joint declaration launched on 21st Jan at the World Economic Forum in Davos, Switzerland. The statement sets out for the first time how governments and industry need to work together to support sustained investment in the new products needed to beat the challenges of rising drug resistance.
Sugar-sweetened beverages account for every one in 200 deaths caused by India’s rising tide of cardiovascular disease, diabetes and obesity, according to a 2015 study.
